Compare stocks

Galenica AG operates within the healthcare sector, focusing on pharmaceutical distribution, retail, and services in Switzerland. Its core business includes the distribution of medicines and health products, operating one of the largest pharmacy networks, and providing specialized healthcare logistics and digital services. Founded in 1927 and headquartered in Bern, Switzerland, Galenica leverages its extensive network and partnerships to maintain a strong presence in the Swiss market. The company is strategically positioned through its integration across the pharmaceutical supply chain, offering a comprehensive range of products and services to improve healthcare accessibility and efficiency.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.